I was puzzled that Absaroka would choose to go after a $2.50 stock with little or no stock borrow, and I am equally puzzled why the firm would use arguments that are so easily refutable. Some of the points raised clearly deserve attention and a detailed response by management, but the easily refuted points dilute the impact of the report. I have already sent the firm an email, and I hope to get a better understanding of our differences of opinion. Disclosure: The author holds no positions in any of the stocks mentioned. The author can be reached for comments at firstname.lastname@example.org.